Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristin L Nichol

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Vaccine|August 2, 2006
Heterogeneity of influenza case definitions and implications for interpreting and comparing study resultsKristin L Nichol
Drugs & Aging|June 25, 2005
Influenza vaccination in the elderly: impact on hospitalisation and mortalityKristin L Nichol
Vaccine|February 21, 2009
Efficacy and effectiveness of influenza vaccinationKristin L Nichol
Vaccine|October 21, 2009
Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversyKristin L Nichol
Infection Control and Hospital Epidemiology|December 3, 2003
First do no harm: ensuring that healthcare workers vaccinate and are vaccinatedKristin L Nichol
The Journal of Infectious Diseases|February 2, 2010
Pneumococcal vaccination and revaccination in the elderly populationKristin L Nichol
Cleveland Clinic Journal of Medicine|November 30, 2006
Improving influenza vaccination rates among adultsKristin L Nichol
Vaccine|April 11, 2003
The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccinesKristin L Nichol
Vaccine|August 9, 2011
Cost-effectiveness and socio-economic aspects of childhood influenza vaccinationKristin L Nichol
Vaccine|July 12, 2002
Cost effectiveness of influenza vaccination for healthy persons between ages 65 and 74 yearsKristin L Nichol, Michael Goodman
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Vaccine|August 2, 2006
Heterogeneity of influenza case definitions and implications for interpreting and comparing study resultsKristin L Nichol
Drugs & Aging|June 25, 2005
Influenza vaccination in the elderly: impact on hospitalisation and mortalityKristin L Nichol
Vaccine|February 21, 2009
Efficacy and effectiveness of influenza vaccinationKristin L Nichol
Vaccine|October 21, 2009
Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversyKristin L Nichol
Infection Control and Hospital Epidemiology|December 3, 2003
First do no harm: ensuring that healthcare workers vaccinate and are vaccinatedKristin L Nichol
The Journal of Infectious Diseases|February 2, 2010
Pneumococcal vaccination and revaccination in the elderly populationKristin L Nichol
Cleveland Clinic Journal of Medicine|November 30, 2006
Improving influenza vaccination rates among adultsKristin L Nichol
Vaccine|April 11, 2003
The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccinesKristin L Nichol
Vaccine|August 9, 2011
Cost-effectiveness and socio-economic aspects of childhood influenza vaccinationKristin L Nichol
Vaccine|July 12, 2002
Cost effectiveness of influenza vaccination for healthy persons between ages 65 and 74 yearsKristin L Nichol, Michael Goodman
Pageof 6